John H. Stewart

8.4k total citations · 2 hit papers
136 papers, 6.0k citations indexed

About

John H. Stewart is a scholar working on Surgery, Oncology and Emergency Medicine. According to data from OpenAlex, John H. Stewart has authored 136 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 33 papers in Oncology and 27 papers in Emergency Medicine. Recurrent topics in John H. Stewart's work include Intraperitoneal and Appendiceal Malignancies (38 papers), Appendicitis Diagnosis and Management (27 papers) and Ovarian cancer diagnosis and treatment (24 papers). John H. Stewart is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (38 papers), Appendicitis Diagnosis and Management (27 papers) and Ovarian cancer diagnosis and treatment (24 papers). John H. Stewart collaborates with scholars based in United States, Australia and New Zealand. John H. Stewart's co-authors include Margaret McCredie, Edward A. Levine, Perry Shen, Stephen P. McDonald, Claire M. Vajdic, Marina T. van Leeuwen, Angela C Webster, Jeremy R. Chapman, Andrew E. Grulich and Konstantinos I. Votanopoulos and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

John H. Stewart

128 papers receiving 5.8k citations

Hit Papers

Cancer Incidence Before and After Kidney Transplantation 1999 2026 2008 2017 2006 1999 250 500 750

Peers

John H. Stewart
John H. Stewart Australia
Trevor Baglin United Kingdom
John L. Gore United States
George P. Canellos United States
Patrik Finne Finland
John H. Stewart Australia
John H. Stewart
Citations per year, relative to John H. Stewart John H. Stewart (= 1×) peers John H. Stewart

Countries citing papers authored by John H. Stewart

Since Specialization
Citations

This map shows the geographic impact of John H. Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Stewart more than expected).

Fields of papers citing papers by John H. Stewart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Stewart. The network helps show where John H. Stewart may publish in the future.

Co-authorship network of co-authors of John H. Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Stewart. A scholar is included among the top collaborators of John H. Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Stewart. John H. Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alimi, Yewande, Linda Barry, Andre R. Campbell, et al.. (2025). A qualitative study of micro and macroaggression experienced by Black surgical trainees through an anonymous reporting. The American Journal of Surgery. 247. 116371–116371.
2.
Kumar, Vijay & John H. Stewart. (2024). cGLRs Join Their Cousins of Pattern Recognition Receptor Family to Regulate Immune Homeostasis. International Journal of Molecular Sciences. 25(3). 1828–1828. 8 indexed citations
3.
Kumar, Vijay, et al.. (2023). Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME. Journal of Biomedical Science. 30(1). 48–48. 16 indexed citations
4.
Kumar, Vijay, et al.. (2023). Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology. European Journal of Cell Biology. 102(3). 151338–151338. 14 indexed citations
5.
Fayanju, Oluwadamilola M., Yi Ren, Samantha M. Thomas, et al.. (2019). A Case-Control Study Examining Disparities in Clinical Trial Participation Among Breast Surgical Oncology Patients. JNCI Cancer Spectrum. 4(2). pkz103–pkz103. 14 indexed citations
6.
Votanopoulos, Konstantinos I., Katrina Swett, Aaron U. Blackham, et al.. (2013). Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis from Rectal Cancer. Annals of Surgical Oncology. 20(4). 1088–1092. 22 indexed citations
7.
Kimmick, Gretchen, Fabian Camacho, Wenke Hwang, et al.. (2012). Adjuvant radiation and outcomes after breast conserving surgery in publicly insured patients. Journal of Geriatric Oncology. 3(2). 138–146. 5 indexed citations
8.
McQuellon, Richard P., Gregory B. Russell, Craig S. Cashwell, et al.. (2012). Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). Journal of Surgical Oncology. 106(4). 376–380. 22 indexed citations
9.
Camacho, Fabian, et al.. (2008). Patterns of care analysis among women with ductal carcinoma in situ in North Carolina. The American Journal of Surgery. 195(2). 164–169. 19 indexed citations
10.
Stewart, John H., Perry Shen, Greg Russell, et al.. (2008). A Phase I Trial of Oxaliplatin for Intraperitoneal Hyperthermic Chemoperfusion for the Treatment of Peritoneal Surface Dissemination from Colorectal and Appendiceal Cancers. Annals of Surgical Oncology. 15(8). 2137–2145. 55 indexed citations
11.
Stewart, John H., Perry Shen, & Edward A. Levine. (2007). Patient Selection for Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion. PubMed. 134. 215–229. 2 indexed citations
12.
McQuellon, Richard P., Suzanne C. Danhauer, Gregory B. Russell, et al.. (2007). Monitoring Health Outcomes Following Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis. Annals of Surgical Oncology. 14(3). 1105–1113. 56 indexed citations
13.
Stewart, John H., Margaret McCredie, Sheila Williams, & Stephen P. McDonald. (2004). Interpreting incidence trends for treated end‐stage renal disease: Implications for evaluating disease control in Australia. Nephrology. 9(4). 238–246. 25 indexed citations
14.
Weiser, Todd S., Zong Sheng Guo, Galen A. Ohnmacht, et al.. (2001). Sequential 5-Aza-2’-deoxycytidine-Depsipeptide FR901228 Treatment Induces Apoptosis Preferentially in Cancer Cells and Facilitates Their Recognition by Cytolytic T Lymphocytes Specific for NY-ESO-1. Journal of Immunotherapy. 24(2). 151–161. 142 indexed citations
15.
Schlehofer, Brigitte, Wolfgang Pommer, Anders Mellemgaard, et al.. (1996). International renal-cell-cancer study. VI. The role of medical and family history. International Journal of Cancer. 66(6). 723–726. 69 indexed citations
16.
McCredie, Margaret & John H. Stewart. (1992). Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes & Control. 3(4). 323–331. 100 indexed citations
17.
McCredie, Margaret, et al.. (1990). Geographical distribution of cancers of the kidney and urinary tract and analgesic nephropathy in Australia and New Zealand. Australian and New Zealand Journal of Medicine. 20(5). 684–688. 4 indexed citations
18.
Stewart, John H., et al.. (1975). Diseases causing end-stage renal failure in New South Wales.. BMJ. 1(5955). 440–443. 32 indexed citations
19.
Stewart, John H., Kenneth M. Cook, Jennifer Johnston, et al.. (1970). Tissue Matching and Early Rejection of Cadaveric-Donor Renal Allografts: The Importance of Unidentified Donor Antigens. BMJ. 3(5721). 487–490. 15 indexed citations
20.
Stewart, John H. & K. D. G. Edwards. (1965). Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid.. BMJ. 2(5473). 1277–1281. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026